Hao XM - Search Results

1

[Comparison of tolerance and toxicity of CEF-100 regimen versus CEF-60 regimen as adjuvant therapy for breast cancer].

Hui R, Zhang M, Hao XM, Zhang J. Hui R, et al. Among authors: hao xm. Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):871-4. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396651 Clinical Trial. Chinese.

2

[Correlation of Her-2 overexpression with endocrine status and response to tamoxifen treatment in patients with breast cancer].

Zhang J, Zhang JH, Liu Y, Hao XM, Fang ZX, Li SL. Zhang J, et al. Among authors: hao xm. Zhonghua Yi Xue Za Zhi. 2007 Dec 11;87(46):3268-71. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18396622 Chinese.

3

Breast-conserving therapy versus modified radical mastectomy: socioeconomic status determines who receives what--results from case-control study in Tianjin, China.

Liu JJ, Zhang S, Hao X, Xie J, Zhao J, Wang J, Liu L, Wang PP, Zhang J. Liu JJ, et al. Cancer Epidemiol. 2012 Feb;36(1):89-93. doi: 10.1016/j.canep.2011.04.005. Epub 2011 May 25. Cancer Epidemiol. 2012. PMID: 21613000

4

The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.

Ma Y, Hao X, Zhang S, Zhang J. Ma Y, et al. Breast Cancer Res Treat. 2012 Jun;133(2):473-85. doi: 10.1007/s10549-011-1774-x. Epub 2011 Sep 23. Breast Cancer Res Treat. 2012. PMID: 21947651

5

Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.

Hou G, Zhang S, Zhang X, Wang P, Hao X, Zhang J. Hou G, et al. Breast Cancer Res Treat. 2013 Feb;137(3):807-16. doi: 10.1007/s10549-012-2404-y. Epub 2013 Jan 6. Breast Cancer Res Treat. 2013. PMID: 23292119

6

Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.

Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Liu J, et al. Chin J Cancer Res. 2013 Feb;25(1):46-54. doi: 10.3978/j.issn.1000-9604.2012.11.04. Chin J Cancer Res. 2013. PMID: 23372341 Free PMC article.

7

[Protective effect of dexrazoxane on cardiotoxicity in breast cancer patients who received anthracycline-containing chemotherapy].

Wang P, Zhang S, Zhang XB, Li WJ, Hao XM, Zhang J. Wang P, et al. Among authors: hao xm. Zhonghua Zhong Liu Za Zhi. 2013 Feb;35(2):135-9. doi: 10.3760/cma.j.issn.0253-3766.2013.02.013. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23714670 Clinical Trial. Chinese.

8

Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.

Xiao Y, Zhang S, Hou G, Zhang X, Hao X, Zhang J. Xiao Y, et al. Tumour Biol. 2014 Mar;35(3):2035-45. doi: 10.1007/s13277-013-1270-5. Epub 2013 Oct 5. Tumour Biol. 2014. PMID: 24096546

9

Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients.

Li C, Bai J, Hao X, Zhang S, Hu Y, Zhang X, Yuan W, Hu L, Cheng T, Zetterberg A, Lee MH, Zhang J. Li C, et al. Cell Cycle. 2014;13(8):1299-305. doi: 10.4161/cc.28201. Epub 2014 Feb 28. Cell Cycle. 2014. PMID: 24621502 Free PMC article.

10

[Prognostic analyses of occult breast cancer].

Hao X, Zhang S, Liu J, Zhang M, Zhang J. Hao X, et al. Zhonghua Yi Xue Za Zhi. 2014 Sep 30;94(36):2808-11. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25534096 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters